News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Sanofi-Aventis (France) CEO Sees ‘Stunning’ Results for Cancer Drug, BSI-201
June 8, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- Sanofi-Aventis SA achieved “stunning” results in an ongoing human trial for its novel cancer drug aimed at breast and lung tumors, Chief Executive Officer Chris Viehbacher said.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase III
Sanofi (France)
MORE ON THIS TOPIC
Earnings
As Biogen Nears Presymptomatic Alzheimer’s Readout for Leqembi, Can Doctors Be Convinced?
October 30, 2025
·
2 min read
·
Annalee Armstrong
IN PARTNERSHIP WITH ELEMENT
Innovation, Resilience, and the Future of Global Manufacturing
October 30, 2025
·
1 min read
·
BioSpace Insights
CAR-T
Kyverna’s CAR T Therapy Sets ‘New Efficacy Standard’ in Myasthenia Gravis, De-Risking Phase III Trials
October 30, 2025
·
2 min read
·
Tristan Manalac
Immunology and inflammation
Novartis Presents New Data From Potential First Targeted Sjögren’s Treatment
October 29, 2025
·
3 min read
·
Heather McKenzie
